多组学网络分析识别阿片类成瘾中失调的神经生物学通路
研究采用基于网络的机器学习技术,整合阿片使用障碍及处方阿片类药物不当使用的全基因组关联研究结果,与阿片过量死亡者和对照者背外侧前额叶皮层的转录组、蛋白质组及表观遗传数据,识别出211个高度相关基因,涉及Akt、BDNF和ERK通路,并发现414种靶向其中48个成瘾相关基因的药物,部分已获批用于其他物质使用障碍或抑郁症。
要点
- 整合全基因组关联研究与背外侧前额叶皮层多组学数据,识别211个阿片成瘾相关基因。
- 这些基因涉及Akt、BDNF和ERK通路。
- 发现414种药物靶向48个成瘾相关基因,部分已获批治疗其他物质使用障碍或抑郁症。
核心结论
- 采用系统生物学方法整合多组学数据,揭示了可能有助于药物重定位、遗传信息指导的成瘾治疗及未来发现的关键基因靶点。
研究设计与样本
- 研究整合了阿片使用障碍和处方阿片类药物不当使用的全基因组关联研究结果,以及阿片过量死亡者和对照者背外侧前额叶皮层的转录组、蛋白质组和表观遗传数据,使用基于网络的机器学习技术进行分析。
主要发现
- 识别出211个高度相关基因,这些基因由全基因组关联研究识别或在阿片过量死亡者背外侧前额叶皮层中失调,涉及Akt、BDNF和ERK通路。
- 识别出414种药物靶向48个阿片成瘾相关基因,其中部分药物已获批用于治疗其他物质使用障碍或抑郁症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid addiction is a worldwide public health crisis. In the United States, for example, opioids cause more drug overdose deaths than any other substance. However, opioid addiction treatments have limited efficacy, meaning that additional treatments are needed. METHODS: To help address this problem, we used network-based machine learning techniques to integrate results from genome-wide association studies of opioid use disorder and problematic prescription opioid misuse with transcriptomic, proteomic, and epigenetic data from the dorsolateral prefrontal cortex of people who died of opioid overdose and control individuals. RESULTS: We identified 211 highly interrelated genes identified by genome-wide association studies or dysregulation in the dorsolateral prefrontal cortex of people who died of opioid overdose that implicated the Akt, BDNF (brain-derived neurotrophic factor), and ERK (extracellular signal-regulated kinase) pathways, identifying 414 drugs targeting 48 of these opioid addiction-associated genes. Some of the identified drugs are approved to treat other substance use disorders or depression. CONCLUSIONS: Our synthesis of multiomics using a systems biology approach revealed key gene targets that could contribute to drug repurposing, genetics-informed addiction treatment, and future discovery.
引用
- Sullivan KA, Kainer D, Lane M, et al. Multiomic Network Analysis Identifies Dysregulated Neurobiological Pathways in Opioid Addiction. Biol Psychiatry. 2024. PMID: 39615775. doi:10.1016/j.biopsych.2024.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。